thiazolyl blue has been researched along with cholecystokinin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jang, JY; Kim, SW; Ku, JL; Park, JG; Park, YH | 1 |
| Chen, L; Dong, X; Fu, L; Hong, M; Wang, C; Wei, L; Yu, H; Zhang, J | 1 |
2 other study(ies) available for thiazolyl blue and cholecystokinin
| Article | Year |
|---|---|
Presence of CCK-A, B receptors and effect of gastrin and cholecystokinin on growth of pancreatobiliary cancer cell lines.
Topics: Biliary Tract Neoplasms; Cell Count; Cell Division; Cell Line, Tumor; Cholecystokinin; Gastrins; Hormone Antagonists; Humans; Pancreatic Neoplasms; Receptor, Cholecystokinin A; Receptor, Cholecystokinin B; Reverse Transcriptase Polymerase Chain Reaction; Tetrazolium Salts; Thiazoles | 2005 |
Protective effect of cholecystokinin octapeptide on angiotensin II-induced apoptosis in H9c2 cardiomyoblast cells.
Topics: Angiotensin II; Animals; Apoptosis; Benzimidazoles; Cell Line; Cell Survival; Cholecystokinin; Gene Expression Profiling; Gene Expression Regulation; Myocardium; Myocytes, Cardiac; Peptides; Phosphatidylinositol 3-Kinases; Rats; Signal Transduction; Tetrazolium Salts; Thiazoles | 2020 |